共 50 条
- [1] Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinomaANNALS OF ONCOLOGY, 2015, 26 (07) : 1476 - 1480Massarelli, E.Lin, H.Ginsberg, L. E.Tran, H. T.Lee, J. J.Canales, J. R.Williams, M. D.Blumenschein, G. R., Jr.Lu, C.Heymach, J. V.Kies, M. S.Papadimitrakopoulou, V.
- [2] Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and NeckHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2025,Bhatia, AartiMehra, RaneeBauman, JessicaKhan, Saad A.Wei, WeiNeumeister, VeroniqueSandoval-Schaefer, TeresaAlpaugh, R. KatherineLango, MiriamRimm, David L.Ridge, John A.Burtness, Barbara
- [3] Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinomaHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 (12): : 1759 - 1764Geiger, Jessica L.Bauman, Julie E.Gibson, Michael K.Gooding, William E.Varadarajan, PrakashKotsakis, AthanasiosMartin, DanielGutkind, Jorge SilvioHedberg, Matthew L.Grandis, Jennifer R.Argiris, Athanassios
- [4] Phase II trial of everolimus in patients with previously treated recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)Varadarajan, PrakashKotsakis, Athanasios PanayotisMartin, DanielGutkind, Jorge SilvioGibson, Michael K.Argiris, Athanassios
- [5] A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinomaORAL ONCOLOGY, 2013, 49 (05) : 461 - 467Bauman, Julie E.Arias-Pulido, HugoLee, Sang-JoonFekrazad, M. HoumanOzawa, HiroyukiFertig, ElanaHoward, JasonBishop, JustinWang, HaoOlson, Garth T.Spafford, Michael J.Jones, Dennie V.Chung, Christine H.
- [6] A phase II trial of vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neckAMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (04): : 398 - 400Saxman, SMann, BCanfield, VLoehrer, PVokes, E
- [7] Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinomaJOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) : 3766 - 3773Elser, ChristineSiu, Lillian L.Winquist, EricAgulnik, MarkPond, Gregory R.Chin, Soo F.Francis, PeggyCheiken, RobinElting, JamesMcNabola, AngelaWilkie, DeanPetrenciuc, OanaChen, Eric X.
- [8] A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neckHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (12): : 1054 - 1059Espinosa, EZamora, PMillá, AMorales, SMolina, RMira, MBarón, MG
- [9] Phase II trial of sunitinib in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Choong, N. W.Cohen, E. E.Kozloff, M. F.Taber, D.Wade, J. L., IIIHu, S.Ivy, S. P.Nichols, K.Dekker, A.Vokes, E. E.
- [10] Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II studyLANCET ONCOLOGY, 2009, 10 (03): : 247 - 257Cohen, Ezra E. W.Davis, Darren W.Karrison, Theodore G.Seiwert, Tanguy Y.Wong, Stuart J.Nattam, SreenivasaKozloff, Mark F.Clark, Joseph I.Yan, Duen-HwaLiu, WenPierce, CarolynDancey, Janet E.Stenson, KerstinBlair, ElizabethDekker, AllisonVokes, Everett E.